Novel non-endocytic delivery of antisense oligonucleotides

Advanced Drug Delivery Reviews

Volumn 44, Issue 1, 2000, Pages 35-49

  Dokka, Sujatha ^a   Rojanasakul, Yon ^a  

^a WEST VIRGINIA UNIVERSITY   (United States)

Author keywords

Antisense; Delivery; Membrane; Oligonucleotides; Trafficking; Transport; Uptake

Indexed keywords

AGENTS; BIOLOGICAL MEMBRANES; DNA SEQUENCES; DRUG PRODUCTS; RNA;

ANTISENSE OLIGONUCLEOTIDES; ENDOCYTIC PROCESS;

CONTROLLED DRUG DELIVERY;

ANTISENSE OLIGONUCLEOTIDE; LIPID; LIPOSOME; NANOPARTICLE; PEPTIDE; POLYLYSINE; RECEPTOR; RNA; SIGNAL PEPTIDE; STREPTOLYSIN O;

BASE PAIRING; CELL MEMBRANE PERMEABILITY; CELL NUCLEUS; CYTOPLASM; DRUG DELIVERY SYSTEM; DRUG DESIGN; ELECTROPORATION; ENDOCYTOSIS; ENDOSOME; GENE TARGETING; GENE THERAPY; MICROINJECTION; NUCLEIC ACID HYBRIDIZATION; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REVIEW; RNA STRUCTURE;

EID: 0034739609     PISSN: 0169409X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-409X(00)00082-X     Document Type: Article

References (101)

1. Gao W.Y., Strom C., Egan W., Cheng Y.C. Cellular pharmacology of phosphorothioate homooligodeoxynucleotides in human cells. Mol. Pharmacol. 43:1993;45-50.
2. Temsamani J., Kubert M., Tang J., Padmapriya A., Agrawal S. Cellular uptake of oligodeoxynucleotide phosphorothioates and their analogs. Antisense Res. Dev. 4:1994;35-42.
3. Stein C.A., Mori K., Loke S.L., Subasinghe C., Cohen J.S., Neckers L.M. Phosphorothioate and normal oligodeoxyribonucleotides with 5′-linked acridine: characterization and preliminary kinetics of cellular uptake. Gene. 72:1988;333-341.
4. Loke S.L., Stein C.A., Zhang X.H., Mori K., Nakaniski M., Cohen J., Neckers L.M. Characterization of oligonucleotide transport into living cells. Proc. Natl. Acad. Sci. USA. 86:1989;3474-3478.
5. Yakubov L.A., Deeva E.A., Zarytova V.F., Ivanova E.M., Ryte A.S., Yurchenko V.L., Vlassov V.V. Mechanism of oligonucleotide uptake by cells: involvement of specific receptors? Proc. Natl. Acad. Sci. USA. 86:1989;6454-6458.
6. Akhtar S., Basu S., Wickstrom E., Juliano R.L. Interactions of antisense DNA oligonucleotide analogs with phospholipid membranes (liposomes). Nucleic Acids Res. 19:1991;5551-5559.
7. Wu-Pong S., Weiss T.L., Hunt C.A. Antisense c-myc oligodeoxyribonucleotide cellular uptake. Pharm. Res. 9:1992;1010-1017.
8. Bennett R.M., Gabor G.T., Morritt M.J. DNA binding to human leukocytes. J. Clin. Invest. 76:1985;2182-2190.
9. Beltinger C., Saragovi H.U., Smith R.M., LeSauteur L., Shah N., DeDionisio L., Christensen L., Raible A., Jarett L., Gewirtz A.M. Binding, uptake, and intracellular trafficking of phosphorothioate-modified oligodeoxynucleotides. J. Clin. Invest. 95:1995;1814-1823.
10. Marti, G.E., Zon, G., Egan, W., Noguchi, P., Matsukura, M., Broder, S., In: Oligodeoxynucleotides as Antisense Inhibitors of Gene Expression: Therapeutic Implications, 1989, Rockville, MD.
11. Miller P.S., McParland K.B., Jayaraman K., Ts'o P.O.P. Biochemical and biological effects of nonionic nucleic acid methylphosphonates. Biochemistry. 20:1981;1874-1880.
12. Shoji Y., Akhtar S., Periasamy A., Herman B., Juliano R.L. Mechanism of cellular uptake of modified oligodeoxynucleotides containing methylphosphonate linkages. Nucleic Acids Res. 19:1991;5543-5550.
13. Cerruzzi M., Draper K., Schwartz J. Natural and phosphorothioate-modified oligodeoxynucleotides exhibit a non-random cellular distribution. Nucleos. Nucleot. 9:1990;679-695.
14. Hawley P., Gibson I. The detection of oligodeoxynucleotide molecules following uptake into mammalian cells. Antisense Res. Dev. 2:1992;119-127.
15. Felgner P.L., Gadek Y.R., Holm M., Roman R., Chan H.W., Wenz M., Northop J.P., Ringold G.M., Danielson M. Lipofectin: a highly efficient, lipid-mediated DNA-transfection procedure. Proc. Natl. Acad. Sci. USA. 84:1987;7413-7417.
16. Bennett F.C., Chiang M.Y., Chan H., Grimm S. Use of cationic lipids to enhance the biological activity of antisense oligonucleotides. J. Liposome Res. 3:1993;85-102.
17. Farhood H., Gao X., Son K., Yang Y.Y., Lazo J.S., Huang L. Cationic liposomes for direct gene transfer in therapy of cancer and other diseases. Ann. NY Acad. Sci. 716:1994;23-35.
18. Huang L., Connor J., Wang C.Y. pH-sensitive immunoliposomes. Methods Enzymol. 149:1987;88-99.
19. Chu C.J., Dijkstra J., Lai M.Z., Hong K., Szoka F.C. Efficiency of cytoplasmic delivery by pH-sensitive liposomes in cells in culture. Pharm. Res. 7:1990;824-834.
20. Ropert C., Lavignon M., Duberner C., Couvreur P., Malvy C. Oligonucleotides encapsulated in pH sensitive liposomes are efficient towards Friend retrovirus. Biochem. Biophys. Res. Commun. 183:1992;879-885.
21. Leonetti J.P., Machy P., Degols G., Lebleu B., Leserman L. Antibody targeted liposomes containing oligodeoxyribonucleotide sequences complementary to viral RNA selectively inhibit viral replication. Proc. Natl. Acad. Sci. USA. 87:1990;2448-2451.
22. Leserman L., Degols G., Machy P., Leonetti J.P., Mechti N., Lebleu B. Targeting and intracellular delivery of antisense oligonucleotides interfering with oncogene expression. Wickstrom E. Prospects for Antisense Nucleic Acid Therapy of Cancers and AIDS. 1991;25 Wiley-Liss Inc, New York.
23. Renneisen K., Leserman L., Matthes E., Schroder H.C., Muller W.E.G. Inhibition of expression of human immunodeficiency virus-1 in vitro by antibody-targeted liposomes containing antisense RNA to the env region. J. Biol. Chem. 265:1990;16337-16342.
24. Boutorin A.S., Gus'kova L.V., Ivanova E.M., Kobetz N.D., Zarytova V.F., Ryte A.S., Yurchenko L.V., Vlassov V.V. Synthesis of alkylating oligonucleotide derivatives containing cholesterol of phenazinium residues at their 3′-terminus and their interaction with DNA within mammalian cells. FEBS Lett. 254:1989;129-132.
25. Letsinger R.L., Zhang G.R., Sun D.K., Ikeuchi T., Sarin P.S. Cholesteryl-conjugated oligonucleotides: synthesis, properties and activity as inhibitors of replication of human immunodeficiency virus in cell culture. Proc. Natl. Acad. Sci. USA. 86:1989;6553-6556.
26. Shea R.G., Marsters J.C., Bischofberger N. Synthesis, hybridization properties and antiviral activity of lipid-oligodeoxynucleotide conjugates. Nucleic Acids Res. 18:1990;3777-3783.
27. Vlassov V.V., Balakireva L.A., Yakubov L.A. Transport of oligonucleotides across natural and model membranes. Biochim. Biophys. Acta. 1197:1994;95-108.
28. Smidt P.C., Doan T.L., Falco S., van Berkel T.J.C. Association of antisense oligonucleotides with lipoproteins prolongs the plasma half-life and modifies the tissue distribution. Nucleic Acids Res. 19:1991;4695-4700.
29. Krieg A.M., Tonkinson J., Matson S., Zhao Q., Saxon M., Zhang L.M., Banja U., Yakubov L., Stein C.A. Modification of antisense phosphodiester oligodeoxynucleotides by a 5′ cholesteryl moiety increases cellular association and improves efficacy. Proc. Natl. Acad. Sci. USA. 90:1993;1048-1052.
30. Ryser H.J.P., Shen W.C. Conjugation of methotrexate to poly(L-lysine) increases drug transport and overcomes drug resistance in cultured cells. Proc. Natl. Acad. Sci. USA. 75:1978;3867-3870.
31. Lemaitre M., Bayard B., Lebleu B. Specific antiviral activity of poly (L-lysine) conjugated oligodeoxyribonucleotide sequences complementary to vesicular stomatitis virus N protein mRNA initiation site. Proc. Natl. Acad. Sci. USA. 84:1987;648-652.
32. Leonetti J.P., Rayner B., Lemaitre M., Gagnor C., Milhaud P.G., Imbach J.L., Lebleu B. Antiviral activity of conjugates between poly (L-lysine) and synthetic oligodeoxyribonucleotides. Gene. 72:1988;323-332.
33. Stevenson M., Iversen P.L. Inhibition of human immunodeficiency virus type 1-mediated cytopathic effect by poly(L-lysine)-conjugated synthetic antisense oligodeoxyribonucleotides. J. Gen. Virol. 70:1989;2673-2682.
34. Degols G., Leonetti J.P., Mechti N., Lebleu B. Antiproliferative effects of antisense oligonucleotides directed to the c-myc oncogene. Nucleic Acids Res. 19:1991;945-953.
35. Degols G., Leonetti J.P., Milhaud P., Mechti N., Lebleu B. Antisense inhibitors of HIV: problems and perspective. Antivir. Res. 17:1992;279-287.
36. Leonetti J.P., Degols G., Lebleu B. Biological activity of oligonucleotide-poly(L-lysine) conjugates: mechanisms of cell uptake. Bioconj. Chem. 1:1990;149-153.
37. Chavany C., Le Doan T., Couvreur P., Puisieux F., Helene C. Polyalkylcyanoacrylate nanoparticles as polymeric carriers for antisense oligonucleotides. Pharm. Res. 9:1992;441-449.
38. Chavany C., Saison-Behmoaras T., Le Doan T., Puisieux F., Couvreur P., Helene C. Adsorption of oligonucleotides onto polyisohexylcyano-acrylate nanoparticles protects them against nucleases and increases their cellular uptake. Pharm. Res. 11:1994;1370-1378.
39. Citro G., Perrotti D., Cucco C., D'Agnano I., Sacchi A., Zupi G., Calabretta B. Inhibition of leukemia cell proliferation by receptor-mediated uptake of c-myb antisense oligodeoxynucleotides. Proc. Natl. Acad. Sci. USA. 89:1992;7031-7035.
40. Citro G., Szczylik C., Ginobbi P., Zupi G., Calabretta B. Inhibition of leukemia cell proliferation by folic acid-polylysine-mediated introduction of c-myb antisense oligodeoxynucleotides into HL-60 cells. Br. J. Cancer. 69:1994;463-467.
41. Wu G.Y., Wu C.H. Specific inhibition of hepatitis B viral gene expression in vitro by targeted antisense oligonucleotides. J. Biol. Chem. 267:1992;12436-12439.
42. Deshpande D., Toledo-Velasquez D., Thakkar D., Liang W.W., Rojanasakul Y. Enhanced cellular uptake of oligonucleotides by EGF receptor-mediated endocytosis in A549 cells. Pharm. Res. 13:1996;1-5.
43. Liang W.W., Shi X., Deshpande D., Malanga C.J., Rojanasakul Y. Oligonucleotide targeting to alveolar macrophages by mannose receptor-mediated endocytosis. Biochim. Biophys. Acta. 1279:1995;227-234.
44. Bonfils E., Depierreux C., Midoux P., Thuong N.T., Monsigny M., Roche A.C. Drug targeting: synthesis and endocytosis of oligonucleotide-neoglycoprotein conjugates. Nucleic Acids Res. 20:1992;4621-4629.
45. Zhao Q., Matson S., Herrera C.J., Fisher E., Yu H., Krieg A.M. Comparison of cellular binding and uptake of antisense phosphodiester, phosphorothioate, and mixed phosphorothioate and methylphosphonate oligonucleotides. Antisense Res. Dev. 3:1993;53-66.
46. Chin D.J., Green G.A., Zon G., Szoka F.J., Straubinger R.M. Rapid nuclear accumulation of injected oligodeoxyribonucleotides. New Biol. 2:1990;1091-1100.
47. Leonetti J.P., Mechti N., Degols G., Gagnor C., Lebleu B. Intracellular distribution of microinjected antisense oligonucleotides. Proc. Natl. Acad. Sci. USA. 88:1991;2702-2706.
48. Kleuss C., Hescheler J., Ewel C., Rosenthal W., Schultz G., Wittig B. Assignment of G-protein subtypes to specific receptors inducing inhibition of calcium currents. Nature. 353:1991;43-48.
49. Flanagan W.M., Wagner R.W. Potent and selective gene inhibition using antisense oligodeoxynucleotides. Mol. Cell. Biochem. 172:1997;213-225.
50. Fisher T.L., Terhorst T., Cao X., Wagner R.W. Intracellular disposition and metabolism of fluorescently labeled unmodified and modified oligodeoxynucleotides microinjected into mammalian cells. Nucleic Acids Res. 21:1993;3857-3865.
51. O'Keefe S.J., Wolfes H., Kiessling A., Cooper G.M. Microinjection of antisense c-mos oligonucleotides prevents meiosis II in the maturing mouse egg. Proc. Natl. Acad. Sci. USA. 86:1989;7038-7042.
52. Barry E.L.R., Gesek F.A., Friedman P.A. Introduction of antisense oligonucleotides into cells by permeabilization with streptolysin O. Biotechniques. 15:1993;1018-1020.
53. Giles R.V., Spiller D.G., Tidd D.M. Detection of ribonuclease H-generated mRNA fragments in human leukemia cells following reversible membrane permeabilization in the presence of antisense oligodeoxynucleotides. Antisense Res. Dev. 5:1995;23-31.
54. Giles R.V. Selecting optimal oligonucleotide composition for maximal antisense effect following streptolysin O mediated delivery into human leukaemia cells. Nucleic Acids Res. 26:1998;1567-1575.
55. Spiller D.G., Tidd D.M. Nuclear delivery of antisense oligodeoxynucleotides through reversible permeabilization of human leukemia cells with streptolysin O. Antisense Res. Dev. 5:1995;13-21.
56. Spiller D.G., Giles R.V., Grzybowski J., Tidd D.M., Clark R.E. Improving the intracellular delivery and molecular efficacy of antisense oligonucleotides in chronic myeloid leukemia cells: A comparison of streptolysin-O permeabilization, electroporation, and lipophilic conjugation. Blood. 91:1998;4738-4746.
57. Broughton C.M., Spiller D.G., Pender N., Komorovskaya M., Grzybowski J., Giles R.V., Tidd D.M., Clarke R.E. Preclinical studies of streptolysin-O in enhancing antisense oligonucleotide uptake in harvests from chronic myeloid leukaemia patients. Leukemia. 11:1997;1435-1441.
58. Bhakdi S., Tranum-Jensen J., Sziegoleit A. Mechanism of membrane damage by streptolysin O. Infect. Immun. 47:1985;52-60.
59. Ahnert-Hilger G., Mach W., Fohr K.J., Gratzl M. Poration by α-toxin and streptolysin O: an approach to analyze intracellular processes. Methods Cell Biol. 31:1989;63-90.
60. Clark R.T. Transplantation of AS ODN purged autografts in CML. Exp. Hematol. 25:1997;781. abstract.
61. Midoux P., Mayer R., Monsigny M. Membrane permeabilization by alpha-helical peptides: A flow cytometry study. Biochem. Biophys. Acta. 1239:1987;249-256.
62. Pichon C., Freulon I., Midoux P., Mayer R., Monsigny M., Roche A.C. Cytosolic and nuclear delivery of oligonucleotides mediated by an amphiphilic anionic peptide. Antisense Nucleic Acids Drug Development. 7:1997;335-343.
63. Murata M., Sugahara Y., Takahashi S., Ohnishi S. pH-dependent membrane fusion activity of a synthetic twenty amino acid peptide with the same sequence as that of hydrophobic segment of influenza virus hemagglutinin. J. Biochem. 102:1987;957-962.
64. Murata M., Takahashi S., Kagiwada S., Suzuki A., Ohnishi S. pH-Dependent membrane fusion and vesiculation of phospholipid large unilamellar vesicles induced by amphiphilic anionic and cationic peptides. Biochemistry. 31:1992;1986-1992.
65. Murata M., Takahashi S., Shirai Y., Kagiwada S., Hishida R., Ohnishi S. Specificity of amphiphilic anionic peptides for fusion of phospholipid vesicles. Biophys. J. 64:1992;724-734.
66. Skehel J.J., Bizebard T., Bullough P.A., Hughson F.M., Knossow M., Steinhauer D.A., Wharton S.A., Wiley D.C. Membrane fusion by influenza hemagglutinin. Cold Spring Harbor Symp. Quant. Biol. 60:1995;573-580.
67. Allinquant B., Hantraye P., Mailleux P., Moya K., Bouillot C., Prochiantz A. Downregulation of amyloid precursor protein inhibits neurite outgrowth in vitro. J. Cell. Biol. 128:1995;919-927.
68. Chang D.C., Chassy B.M., Saunders J.A., Sowers A.E. Guide to Electroporation and Electrofusion. 1992;Academic Press, Inc, New York.
69. Bergan R., Connell Y., Fahmy B., Neckers L. Electroporation enhances c-myc antisense oligodeoxynucleotide efficacy. Nucleic Acids Res. 21:1993;3567-3573.
70. Bergan R., Hakim F., Schwartz G.N., Kyle E., Cepada R., Szabo J.M., Fowler D., Gress R., Neckers L. Electroporation of synthetic oligodeoxynucleotides: A novel technique for ex vivo bone marrow purging. Blood. 88:1996;731-741.
71. Bergan R., Kyle E., Connell Y., Neckers L. Inhibition of protein-tyrosine kinase activity in intact cells by the aptameric action of oligodeoxynucleotides. Antisense Res. Dev. 5:1995;33-38.
72. Joliot A., Pernelle C., Deagostini-Bazin H., Prochiantz A. Antennapedia homeobox peptide regulates neural morphogenesis. Proc. Natl. Acad. Sci. USA. 88:1991;1864-1868.
73. Bloch-Gallego E., Le Roux I., Joliot A.H., Volovitch M., Henderson C.E., Prochiantz A. Antennapedia homeobox peptide enhances growth and branching of embryonic chicken motoneurons in vitro. J. Cell Biol. 120:1993;485-492.
74. Le Roux I., Joliot A.H., Bloch-Gallego E., Prochiantz A., Volovitch M. Neurotrophic activity of the Antennapedia homeodomain depends on its specific DNA-binding properties. Proc. Natl. Acad. Sci. USA. 90:1993;9120-9124.
75. Theodore L., Derossi D., Chassaing G., Llirbart B., Kubes M., Jordan P., Chneiweiss H., Godement P., Prochiantz A. Intraneuronal delivery of protein kinase C pseudosubstrate leads to growth cone collapse. J. Neurosci. 15:1995;7158-7167.
76. Troy C.M., Derossi D., Prochiantz A., Greene L.A., Shelanski M.L. Downregulation of Cu/Zn superoxide dismutase leads to cell death via the nitric oxide-peroxynitrite pathway. J. Neurosci. 16:1996;253-261.
77. Fawell S., Seery J., Daikh Y., Moore C., Chen L.L., Pepinsky B., Barsoum J. Tat-mediated delivery of heterologous proteins into cells. Proc. Natl. Acad. Sci. USA. 91:1994;664-668.
78. Vives E., Brodin P., Lebleu B. A truncated HIV-1 Tat protein Basic Domain rapidly translocates through the plasma membrane and accumulates in the cell nucleus. J. Biol. Chem. 272:1997;16010-16017.
79. Derossi D., Joliot H.A., Chassaing G., Prochiantz A. The third helix of the Antennapedia homeodomain translocates through biological membranes. J. Biol. Chem. 269:1994;10444-10450.
80. Derossi D., Calvet S., Trembleau A., Brunissen A., Chassaing G., Prochiantz A. Cell internalization of the third helix of the Antennapedia homeodomain is receptor-independent. J. Biol. Chem. 271:1996;18188-18193.
81. Oehlke J., Krause E., Wiesner B., Beyermann M., Bienert M. Nonendocytic, amphipathicity dependent cellular uptake of helical model peptides. Protein Peptide Lett. 3:1996;393-398.
82. Oehlke J., Scheller A., Wiesner B., Krause E., Beyermann M., Klauschenz E., Melzig M., Bienert M. Cellular uptake of an α-helical amphipathic model peptide with the potential to deliver polar compounds into the cell interior non-endocytically. Biochim. Biophys. Acta. 1414:1998;127-139.
83. Oehlke J., Krause E., Wiesner B., Beyermann M., Bienert M. Extensive cellular uptake into endothelial cells of an amphipathic β-sheet forming peptide. FEBS Lett. 415:1997;196-199.
84. Steinmann R.M., Mellmann I.S., Muller W.A., Cohn Z.A. Endocytosis and the recycling of plasma membrane. J. Cell Biol. 96:1983;1-27.
85. Hawiger J. Cellular import of functional peptides to block intracellular signaling. Curr. Opin. Immunol. 9:1997;189-194.
86. Lin Y.Z., Veach R.A., Torgerson T.R., Hawiger J. Inhibition of nuclear translocation of transcription factor NF-kappa B by a synthetic peptide containing a cell membrane-permeable motif and nuclear localization sequence. J. Biol. Chem. 270:1995;14255-14258.
87. Lin Y.Z., Yao S.Y., Hawiger J. Role of the nuclear localization sequence in fibroblast growth factor-1 stimulated mitogenic pathways. J. Biol. Chem. 271:1996;5305-5308.
88. Liu X.Y., Timmons S., Lin Y.Z., Hawiger J. Identification of a functionally important sequence in the cytoplasmic tail of integrin b3 by using cell-permeable peptide analogs. Proc. Natl. Acad. Sci. USA. 93:1996;11819-11824.
89. Rojas M., Yao S.Y., Lin Y.Z. Controlling epidermal growth factor (EGF)-stimulated Ras activation in intact cells by a cell-permeable peptide mimicking phosphorylated EGF receptor. J. Biol. Chem. 271:1996;27456-27461.
90. Rojas M., Yao S., Donahue J.P., Lin Y.Z. An alternative to phosphotyrosine-containing motifs for binding to an SH2 domain. Biochem. Biophys. Res. Commun. 234:1997;675-680.
91. Dokka S., Toledo-Velasquez D., Shi X., Wang L., Rojanasakul Y. Cellular delivery of oligonucleotides by synthetic import peptide carrier. Pharm. Res. 14:1997;1759-1764.
92. Morris M.C., Vidal P., Chaloin L., Heitz F., Divita G. A new peptide vector for efficient delivery of oligonucleotides into mammalian cells. Nucleic Acids Res. 25:1997;2730-2736.
93. von Heijne G. The signal peptide. J. Membr. Biol. 115:1990;195-201.
94. von Heijne G. Transcending the impenetrable: How proteins come to terms with membranes. Biochim. Biophys. Acta. 947:1988;307-333.
95. De Kruijf B. Anionic phospholipids and protein translocation. FEBS Lett. 346:1994;78-82.
96. Rapoport T.A., Jungnickel B., Kutay U. Protein transport across the eukaryotic endoplasmic reticulum and bacterial inner membranes. Annu. Rev. Biochem. 65:1996;271-303.
97. Du C., Yao S., Rojas M., Lin X.Y. Conformational and topological requirements of cell-permeable peptide function. J. Peptide Res. 51:1998;235-243.
98. Chaloin L., Vidal P., Heitz A., Van Mau N., Mery J., Divita G., Heitz F. Conformations of primary amphipathic carrier peptides in membrane mimicking environments. Biochemistry. 36:1997;11179-11187.
99. Kalderon D., Richardson W.D., Markham A.F., Smith A.M. Sequence requirements for nuclear location of simian virus 40 large-T antigen. Nature. 311:1984;33-38.
100. Dingwall C., Laskey R. The nuclear membrane. Science. 258:1992;942-947.
101. Soukchareun S., Tregear G.W., Haralambidis J. Preparation and characterization of antisense oligonucleotide-peptide hybrids containing viral fusion peptides. Bioconjug. Chem. 6:1995;43-53.